Table 1 Clinicopathological characteristics of 120 patients with well-differentiated PanNEN
Patient characteristics | n = 120 | % |
|---|---|---|
Age, median(range) | 60 (12‒88) | |
Sex | ||
Male | 49 | 40.8 |
Female | 71 | 59.2 |
NLR, median (range) | 1.93 (0.44‒5.32) | |
MLR, median (range) | 0.23 (0.11‒0.53) | |
PLR, median (range) | 145.2 (42.5‒328.8) | |
PWR, median (range) | 43.7 (11.9‒120) | |
Albumin(g/L), median (range) | 41.0 (28‒49) | |
Tumor size (mm), median (range) | 14.5 (4‒168) | |
Operative procedures | ||
PD | 38 | 31.7 |
DP | 58 | 48.3 |
TP | 2 | 1.7 |
Partial resection | 22 | 18.3 |
Surgical approach | ||
Open | 78 | 65.0 |
Laparoscopy | 42 | 35.0 |
Surgical margin status | ||
R0 | 116 | 96.7 |
R1 | 4 | 3.3 |
Tumor location | ||
Head | 47 | 39.2 |
Body/tail | 68 | 56.7 |
Multiple | 5 | 4.2 |
Ki-67 (%), median (range) | 1.83 (0.02‒28) | |
Clinical stage | ||
I | 74 | 61.7 |
II | 27 | 23.3 |
III | 19 | 15.0 |
2017 WHO classification | ||
G1 | 73 | 60.8 |
G2 | 45 | 37.5 |
G3 | 2 | 1.7 |
Hormonal function | ||
No | 70 | 58.3 |
Yes | 50 | 41.7 |
Lymph node metastasis | ||
No | 102 | 85.0 |
Yes | 18 | 15.0 |
Lymphatic invasion | ||
No | 105 | 87.5 |
Yes | 15 | 12.5 |
Venous invasion | ||
No | 91 | 75.8 |
Yes | 29 | 24.2 |